Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome.
Wick
A
A
Schäfer
N
N
Dörner
N
N
Schemmer
D
D
Platten
M
M
Bendszus
M
M
Wick
W
W
D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001158:Arteries / Q000187:drug effects / Q000503:physiopathology; D000068258:Bevacizumab; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab